The EMA published an version updated of the register of deadlines to put a medicinal product on the market in accordance with Article 33 of the Regulation (EC) n°1901/2006. Marketing-authorisation holders (MAHs) are obliged to place their medicines on the market following completion of an agreed paediatric investigation plan (PIP) within two years of obtaining a paediatric indication: obligation derives from article 33 of the paediatric regulation.
The document includes information on …